Indications and Purposes
| 1. Indications And Usage Besponsa Is Indicated For The Treatment Of Adults With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All). Besponsa Is A Cd22-Directed Antibody-Drug Conjugate (Adc) Indicated For The Treatment Of Adults With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Inotuzumab Ozogamicin |